These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 23099330)

  • 1. A strategy of antigen incorporation into exosomes: comparing cross-presentation levels of antigens delivered by engineered exosomes and by lentiviral virus-like particles.
    Lattanzi L; Federico M
    Vaccine; 2012 Nov; 30(50):7229-37. PubMed ID: 23099330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strong CD8+ T cell antigenicity and immunogenicity of large foreign proteins incorporated in HIV-1 VLPs able to induce a Nef-dependent activation/maturation of dendritic cells.
    Sistigu A; Bracci L; Valentini M; Proietti E; Bona R; Negri DR; Ciccaglione AR; Tritarelli E; Nisini R; Equestre M; Costantino A; Marcantonio C; Santini SM; Lapenta C; Donati S; Tataseo P; Miceli M; Cara A; Federico M
    Vaccine; 2011 Apr; 29(18):3465-75. PubMed ID: 21382480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-tumor CD8+ T cell immunity elicited by HIV-1-based virus-like particles incorporating HPV-16 E7 protein.
    Di Bonito P; Grasso F; Mochi S; Petrone L; Fanales-Belasio E; Mei A; Cesolini A; Laconi G; Conrad H; Bernhard H; Dembek CJ; Cosma A; Santini SM; Lapenta C; Donati S; Muratori C; Giorgi C; Federico M
    Virology; 2009 Dec; 395(1):45-55. PubMed ID: 19800648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor HPV E7-specific CTL activity elicited by in vivo engineered exosomes produced through DNA inoculation.
    Di Bonito P; Chiozzini C; Arenaccio C; Anticoli S; Manfredi F; Olivetta E; Ferrantelli F; Falcone E; Ruggieri A; Federico M
    Int J Nanomedicine; 2017; 12():4579-4591. PubMed ID: 28694699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incorporation of Heterologous Proteins in Engineered Exosomes.
    Manfredi F; Di Bonito P; Arenaccio C; Anticoli S; Federico M
    Methods Mol Biol; 2016; 1448():249-60. PubMed ID: 27317186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA Vectors Generating Engineered Exosomes Potential CTL Vaccine Candidates Against AIDS, Hepatitis B, and Tumors.
    Ferrantelli F; Manfredi F; Chiozzini C; Anticoli S; Olivetta E; Arenaccio C; Federico M
    Mol Biotechnol; 2018 Nov; 60(11):773-782. PubMed ID: 30167966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineered dendritic cells-derived exosomes harboring HIV-1 Nef
    Pordanjani PM; Bolhassani A; Pouriayevali MH; Milani A; Rezaei F
    Int J Biol Macromol; 2024 Jun; 270(Pt 2):132236. PubMed ID: 38768924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HPV-E7 delivered by engineered exosomes elicits a protective CD8⁺ T cell-mediated immune response.
    Di Bonito P; Ridolfi B; Columba-Cabezas S; Giovannelli A; Chiozzini C; Manfredi F; Anticoli S; Arenaccio C; Federico M
    Viruses; 2015 Mar; 7(3):1079-99. PubMed ID: 25760140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lentivirus-based virus-like particles as a new protein delivery tool.
    Muratori C; Bona R; Federico M
    Methods Mol Biol; 2010; 614():111-24. PubMed ID: 20225039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Exosome-Based Vaccine Platform Imparts Cytotoxic T Lymphocyte Immunity Against Viral Antigens.
    Anticoli S; Manfredi F; Chiozzini C; Arenaccio C; Olivetta E; Ferrantelli F; Capocefalo A; Falcone E; Ruggieri A; Federico M
    Biotechnol J; 2018 Apr; 13(4):e1700443. PubMed ID: 29274250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Intracellular Delivery Of Anti-HPV16 E7 scFvs Through Engineered Extracellular Vesicles Inhibits The Proliferation Of HPV-Infected Cells.
    Ferrantelli F; Arenaccio C; Manfredi F; Olivetta E; Chiozzini C; Leone P; Percario Z; Ascione A; Flego M; Di Bonito P; Accardi L; Federico M
    Int J Nanomedicine; 2019; 14():8755-8768. PubMed ID: 31806970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell death induced by the herpes simplex virus-1 thymidine kinase delivered by human immunodeficiency virus-1-based virus-like particles.
    Peretti S; Schiavoni I; Pugliese K; Federico M
    Mol Ther; 2005 Dec; 12(6):1185-96. PubMed ID: 16095973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant human immunodeficiency Pr55gag virus-like particles presenting chimeric envelope glycoproteins induce cytotoxic T-cells and neutralizing antibodies.
    Deml L; Schirmbeck R; Reimann J; Wolf H; Wagner R
    Virology; 1997 Aug; 235(1):26-39. PubMed ID: 9300034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineered exosomes emerging from muscle cells break immune tolerance to HER2 in transgenic mice and induce antigen-specific CTLs upon challenge by human dendritic cells.
    Anticoli S; Aricò E; Arenaccio C; Manfredi F; Chiozzini C; Olivetta E; Ferrantelli F; Lattanzi L; D'Urso MT; Proietti E; Federico M
    J Mol Med (Berl); 2018 Feb; 96(2):211-221. PubMed ID: 29282521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SV40 virus-like particles as an effective delivery system and its application to a vaccine carrier.
    Kawano M; Matsui M; Handa H
    Expert Rev Vaccines; 2013 Feb; 12(2):199-210. PubMed ID: 23414410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimisation of secretion of recombinant HBsAg virus-like particles: Impact on the development of HIV-1/HBV bivalent vaccines.
    Michel M; Lone YC; Centlivre M; Roux P; Wain-Hobson S; Sala M
    Vaccine; 2007 Feb; 25(10):1901-11. PubMed ID: 17005303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective elimination of HIV-1-infected cells by Env-directed, HIV-1-based virus-like particles.
    Peretti S; Schiavoni I; Pugliese K; Federico M
    Virology; 2006 Feb; 345(1):115-26. PubMed ID: 16271741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developments in virus-like particle-based vaccines for HIV.
    Buonaguro L; Tagliamonte M; Visciano ML; Tornesello ML; Buonaguro FM
    Expert Rev Vaccines; 2013 Feb; 12(2):119-27. PubMed ID: 23414404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous CD8
    Ferrantelli F; Chiozzini C; Manfredi F; Giovannelli A; Leone P; Federico M
    Vaccines (Basel); 2021 Mar; 9(3):. PubMed ID: 33801926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of Recombinant HIV-1 p24-Nef Protein in Two Forms as Potential Candidate Vaccines in Three Vehicles.
    Larijani MS; Pouriayevali MH; Sadat SM; Ramezani A
    Curr Drug Deliv; 2020; 17(5):387-395. PubMed ID: 32183667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.